| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | retinoic acid 4-hydroxylase activity | 2.43e-08 | 14 | 46 | 4 | GO:0008401 | |
| GeneOntologyMolecularFunction | linoleic acid epoxygenase activity | 4.57e-08 | 4 | 46 | 3 | GO:0071614 | |
| GeneOntologyMolecularFunction | arachidonate epoxygenase activity | 2.53e-07 | 24 | 46 | 4 | GO:0008392 | |
| GeneOntologyMolecularFunction | arachidonate monooxygenase activity | 4.16e-07 | 27 | 46 | 4 | GO:0008391 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor | 6.36e-07 | 8 | 46 | 3 | GO:0033695 | |
| GeneOntologyMolecularFunction | caffeine oxidase activity | 6.36e-07 | 8 | 46 | 3 | GO:0034875 | |
| GeneOntologyMolecularFunction | aromatase activity | 1.22e-06 | 35 | 46 | 4 | GO:0070330 | |
| GeneOntologyMolecularFunction | estrogen 16-alpha-hydroxylase activity | 1.86e-06 | 11 | 46 | 3 | GO:0101020 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 4.40e-06 | 188 | 46 | 6 | GO:0005201 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen | 4.84e-06 | 49 | 46 | 4 | GO:0016712 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on CH or CH2 groups | 5.11e-06 | 15 | 46 | 3 | GO:0016725 | |
| GeneOntologyMolecularFunction | (R)-limonene 6-monooxygenase activity | 5.19e-06 | 2 | 46 | 2 | GO:0052741 | |
| GeneOntologyMolecularFunction | limonene monooxygenase activity | 5.19e-06 | 2 | 46 | 2 | GO:0019113 | |
| GeneOntologyMolecularFunction | (S)-limonene 6-monooxygenase activity | 5.19e-06 | 2 | 46 | 2 | GO:0018675 | |
| GeneOntologyMolecularFunction | (S)-limonene 7-monooxygenase activity | 5.19e-06 | 2 | 46 | 2 | GO:0018676 | |
| GeneOntologyMolecularFunction | arachidonate 11,12-epoxygenase activity | 3.11e-05 | 4 | 46 | 2 | GO:0008405 | |
| GeneOntologyMolecularFunction | fatty acid omega-1 hydroxylase activity | 5.17e-05 | 5 | 46 | 2 | GO:0120502 | |
| GeneOntologyMolecularFunction | long-chain fatty acid omega-1 hydroxylase activity | 5.17e-05 | 5 | 46 | 2 | GO:0120319 | |
| GeneOntologyMolecularFunction | arachidonate 14,15-epoxygenase activity | 5.17e-05 | 5 | 46 | 2 | GO:0008404 | |
| GeneOntologyMolecularFunction | steroid hydroxylase activity | 6.51e-05 | 34 | 46 | 3 | GO:0008395 | |
| GeneOntologyMolecularFunction | monooxygenase activity | 1.41e-04 | 115 | 46 | 4 | GO:0004497 | |
| GeneOntologyMolecularFunction | calcium ion binding | 2.78e-04 | 749 | 46 | 8 | GO:0005509 | |
| GeneOntologyMolecularFunction | heme binding | 4.32e-04 | 154 | 46 | 4 | GO:0020037 | |
| GeneOntologyMolecularFunction | tetrapyrrole binding | 5.47e-04 | 164 | 46 | 4 | GO:0046906 | |
| GeneOntologyMolecularFunction | iron ion binding | 5.73e-04 | 166 | 46 | 4 | GO:0005506 | |
| GeneOntologyMolecularFunction | metalloendopeptidase inhibitor activity | 6.10e-04 | 16 | 46 | 2 | GO:0008191 | |
| GeneOntologyMolecularFunction | low-density lipoprotein particle binding | 7.76e-04 | 18 | 46 | 2 | GO:0030169 | |
| GeneOntologyMolecularFunction | cargo receptor activity | 9.90e-04 | 85 | 46 | 3 | GO:0038024 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen | 1.02e-03 | 194 | 46 | 4 | GO:0016705 | |
| GeneOntologyMolecularFunction | scavenger receptor activity | 1.76e-03 | 27 | 46 | 2 | GO:0005044 | |
| GeneOntologyMolecularFunction | Wnt-protein binding | 2.78e-03 | 34 | 46 | 2 | GO:0017147 | |
| GeneOntologyMolecularFunction | lipoprotein particle binding | 2.94e-03 | 35 | 46 | 2 | GO:0071813 | |
| GeneOntologyMolecularFunction | protein-lipid complex binding | 2.94e-03 | 35 | 46 | 2 | GO:0071814 | |
| GeneOntologyMolecularFunction | oxygen binding | 3.28e-03 | 37 | 46 | 2 | GO:0019825 | |
| GeneOntologyMolecularFunction | glycosaminoglycan binding | 3.33e-03 | 268 | 46 | 4 | GO:0005539 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent conferring tensile strength | 5.04e-03 | 46 | 46 | 2 | GO:0030020 | |
| GeneOntologyMolecularFunction | growth factor binding | 5.55e-03 | 156 | 46 | 3 | GO:0019838 | |
| GeneOntologyMolecularFunction | nuclear retinoic acid receptor binding | 7.13e-03 | 55 | 46 | 2 | GO:0042974 | |
| GeneOntologyMolecularFunction | endopeptidase inhibitor activity | 8.23e-03 | 180 | 46 | 3 | GO:0004866 | |
| GeneOntologyMolecularFunction | peptidase inhibitor activity | 9.13e-03 | 187 | 46 | 3 | GO:0030414 | |
| GeneOntologyMolecularFunction | endopeptidase regulator activity | 1.11e-02 | 201 | 46 | 3 | GO:0061135 | |
| GeneOntologyBiologicalProcess | epoxygenase P450 pathway | 1.54e-07 | 22 | 46 | 4 | GO:0019373 | |
| GeneOntologyBiologicalProcess | omega-hydroxylase P450 pathway | 3.71e-06 | 14 | 46 | 3 | GO:0097267 | |
| GeneOntologyBiologicalProcess | arachidonate metabolic process | 1.59e-05 | 68 | 46 | 4 | GO:0019369 | |
| GeneOntologyBiologicalProcess | linoleic acid metabolic process | 1.78e-05 | 23 | 46 | 3 | GO:0043651 | |
| GeneOntologyBiologicalProcess | monoterpenoid metabolic process | 7.26e-05 | 6 | 46 | 2 | GO:0016098 | |
| GeneOntologyBiologicalProcess | xenobiotic catabolic process | 7.65e-05 | 37 | 46 | 3 | GO:0042178 | |
| GeneOntologyBiologicalProcess | terpenoid metabolic process | 8.78e-05 | 105 | 46 | 4 | GO:0006721 | |
| GeneOntologyBiologicalProcess | positive regulation of isomerase activity | 1.01e-04 | 7 | 46 | 2 | GO:0010912 | |
| GeneOntologyBiologicalProcess | regulation of isomerase activity | 1.01e-04 | 7 | 46 | 2 | GO:0010911 | |
| GeneOntologyBiologicalProcess | long-chain fatty acid metabolic process | 1.67e-04 | 124 | 46 | 4 | GO:0001676 | |
| GeneOntologyBiologicalProcess | unsaturated fatty acid metabolic process | 1.89e-04 | 128 | 46 | 4 | GO:0033559 | |
| GeneOntologyBiologicalProcess | xenobiotic metabolic process | 2.73e-04 | 141 | 46 | 4 | GO:0006805 | |
| GeneOntologyBiologicalProcess | icosanoid metabolic process | 2.81e-04 | 142 | 46 | 4 | GO:0006690 | |
| GeneOntologyBiologicalProcess | isoprenoid metabolic process | 2.96e-04 | 144 | 46 | 4 | GO:0006720 | |
| GeneOntologyBiologicalProcess | oxidative demethylation | 3.17e-04 | 12 | 46 | 2 | GO:0070989 | |
| GeneOntologyBiologicalProcess | olefinic compound metabolic process | 6.88e-04 | 180 | 46 | 4 | GO:0120254 | |
| GeneOntologyCellularComponent | extracellular matrix | COL2A1 VWC2 NTN4 OTOL1 ADAM19 FCGBP MUC2 LTBP4 MUC4 MUC5AC SPOCK3 IGFBPL1 | 1.21e-08 | 656 | 46 | 12 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | COL2A1 VWC2 NTN4 OTOL1 ADAM19 FCGBP MUC2 LTBP4 MUC4 MUC5AC SPOCK3 IGFBPL1 | 1.25e-08 | 658 | 46 | 12 | GO:0030312 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 1.93e-06 | 530 | 46 | 9 | GO:0062023 | |
| GeneOntologyCellularComponent | mucus layer | 1.42e-05 | 3 | 46 | 2 | GO:0070701 | |
| GeneOntologyCellularComponent | Golgi lumen | 1.78e-03 | 109 | 46 | 3 | GO:0005796 | |
| GeneOntologyCellularComponent | basement membrane | 2.45e-03 | 122 | 46 | 3 | GO:0005604 | |
| GeneOntologyCellularComponent | Cul2-RING ubiquitin ligase complex | 4.81e-03 | 47 | 46 | 2 | GO:0031462 | |
| Domain | VWC | 3.45e-12 | 38 | 45 | 7 | SM00214 | |
| Domain | VWF_dom | 7.32e-12 | 42 | 45 | 7 | IPR001007 | |
| Domain | Growth_fac_rcpt_ | 1.08e-10 | 156 | 45 | 9 | IPR009030 | |
| Domain | VWFC_1 | 2.55e-10 | 36 | 45 | 6 | PS01208 | |
| Domain | VWD | 2.76e-10 | 16 | 45 | 5 | SM00216 | |
| Domain | VWF_type-D | 2.76e-10 | 16 | 45 | 5 | IPR001846 | |
| Domain | VWFD | 2.76e-10 | 16 | 45 | 5 | PS51233 | |
| Domain | VWD | 2.76e-10 | 16 | 45 | 5 | PF00094 | |
| Domain | VWFC_2 | 3.60e-10 | 38 | 45 | 6 | PS50184 | |
| Domain | EGF_1 | SCARF1 NTN4 ADAM19 CELSR2 LTBP4 MUC4 ITGB2 NOTCH4 SLIT3 STAB1 | 3.96e-10 | 255 | 45 | 10 | PS00022 |
| Domain | EGF-like_CS | SCARF1 NTN4 ADAM19 CELSR2 LTBP4 MUC4 ITGB2 NOTCH4 SLIT3 STAB1 | 4.96e-10 | 261 | 45 | 10 | IPR013032 |
| Domain | VWC_out | 7.32e-10 | 19 | 45 | 5 | SM00215 | |
| Domain | VWC | 6.09e-09 | 28 | 45 | 5 | PF00093 | |
| Domain | EGF-like_dom | 6.72e-09 | 249 | 45 | 9 | IPR000742 | |
| Domain | EGF_2 | 1.15e-08 | 265 | 45 | 9 | PS01186 | |
| Domain | Unchr_dom_Cys-rich | 2.07e-08 | 13 | 45 | 4 | IPR014853 | |
| Domain | C8 | 2.07e-08 | 13 | 45 | 4 | SM00832 | |
| Domain | TIL_dom | 2.89e-08 | 14 | 45 | 4 | IPR002919 | |
| Domain | EGF_3 | 8.05e-08 | 235 | 45 | 8 | PS50026 | |
| Domain | EGF | 8.05e-08 | 235 | 45 | 8 | SM00181 | |
| Domain | Laminin_EGF | 1.46e-06 | 35 | 45 | 4 | PF00053 | |
| Domain | Laminin_EGF | 2.04e-06 | 38 | 45 | 4 | IPR002049 | |
| Domain | TIL | 2.83e-06 | 12 | 45 | 3 | PF01826 | |
| Domain | C8 | 2.83e-06 | 12 | 45 | 3 | PF08742 | |
| Domain | Cyt_P450_E_grp-I | 4.08e-06 | 45 | 45 | 4 | IPR002401 | |
| Domain | Cyt_P450_CS | 7.90e-06 | 53 | 45 | 4 | IPR017972 | |
| Domain | CTCK_1 | 1.04e-05 | 18 | 45 | 3 | PS01185 | |
| Domain | CYTOCHROME_P450 | 1.06e-05 | 57 | 45 | 4 | PS00086 | |
| Domain | EGF_CA | 1.09e-05 | 122 | 45 | 5 | SM00179 | |
| Domain | - | 1.13e-05 | 58 | 45 | 4 | 1.10.630.10 | |
| Domain | p450 | 1.13e-05 | 58 | 45 | 4 | PF00067 | |
| Domain | EGF-like_Ca-bd_dom | 1.17e-05 | 124 | 45 | 5 | IPR001881 | |
| Domain | EGF | 1.27e-05 | 126 | 45 | 5 | PF00008 | |
| Domain | EGF_extracell | 1.30e-05 | 60 | 45 | 4 | IPR013111 | |
| Domain | EGF_2 | 1.30e-05 | 60 | 45 | 4 | PF07974 | |
| Domain | Cyt_P450 | 1.30e-05 | 60 | 45 | 4 | IPR001128 | |
| Domain | CT | 1.95e-05 | 22 | 45 | 3 | SM00041 | |
| Domain | Cys_knot_C | 2.90e-05 | 25 | 45 | 3 | IPR006207 | |
| Domain | CTCK_2 | 2.90e-05 | 25 | 45 | 3 | PS01225 | |
| Domain | EGF_LAM_2 | 5.07e-05 | 30 | 45 | 3 | PS50027 | |
| Domain | EGF_LAM_1 | 5.07e-05 | 30 | 45 | 3 | PS01248 | |
| Domain | EGF_Lam | 8.11e-05 | 35 | 45 | 3 | SM00180 | |
| Domain | WxxW_domain | 8.46e-05 | 6 | 45 | 2 | IPR025155 | |
| Domain | Mucin2_WxxW | 8.46e-05 | 6 | 45 | 2 | PF13330 | |
| Domain | Hirudin/antistatin | 1.18e-04 | 7 | 45 | 2 | IPR011061 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 1.22e-04 | 106 | 45 | 4 | IPR000152 | |
| Domain | KAZAL | 1.85e-04 | 46 | 45 | 3 | SM00280 | |
| Domain | KAZAL_2 | 2.37e-04 | 50 | 45 | 3 | PS51465 | |
| Domain | Kazal_dom | 2.51e-04 | 51 | 45 | 3 | IPR002350 | |
| Domain | IB | 8.47e-04 | 18 | 45 | 2 | SM00121 | |
| Domain | PRAME_family | 9.46e-04 | 19 | 45 | 2 | IPR026271 | |
| Domain | IGFBP-like | 1.05e-03 | 20 | 45 | 2 | IPR000867 | |
| Domain | IGFBP | 1.05e-03 | 20 | 45 | 2 | PF00219 | |
| Domain | IGFBP_N_2 | 1.05e-03 | 20 | 45 | 2 | PS51323 | |
| Domain | ZnF_RBZ | 1.39e-03 | 23 | 45 | 2 | SM00547 | |
| Domain | Znf_RanBP2 | 1.64e-03 | 25 | 45 | 2 | IPR001876 | |
| Domain | EGF_Ca-bd_CS | 1.65e-03 | 97 | 45 | 3 | IPR018097 | |
| Domain | EGF_CA | 1.74e-03 | 99 | 45 | 3 | PS01187 | |
| Domain | TNFR | 1.78e-03 | 26 | 45 | 2 | SM00208 | |
| Domain | ASX_HYDROXYL | 1.80e-03 | 100 | 45 | 3 | PS00010 | |
| Domain | hEGF | 2.06e-03 | 28 | 45 | 2 | PF12661 | |
| Domain | TNFR/NGFR_Cys_rich_reg | 2.86e-03 | 33 | 45 | 2 | IPR001368 | |
| Domain | Kazal_2 | 3.39e-03 | 36 | 45 | 2 | PF07648 | |
| Domain | LAM_G_DOMAIN | 3.78e-03 | 38 | 45 | 2 | PS50025 | |
| Domain | Laminin_G_2 | 4.18e-03 | 40 | 45 | 2 | PF02210 | |
| Pathway | REACTOME_XENOBIOTICS | 1.43e-07 | 23 | 30 | 4 | M5372 | |
| Pathway | KEGG_LINOLEIC_ACID_METABOLISM | 3.81e-07 | 29 | 30 | 4 | M2920 | |
| Pathway | REACTOME_SYNTHESIS_OF_EPOXY_EET_AND_DIHYDROXYEICOSATRIENOIC_ACIDS_DHET | 4.84e-07 | 8 | 30 | 3 | M27135 | |
| Pathway | REACTOME_SYNTHESIS_OF_16_20_HYDROXYEICOSATETRAENOIC_ACIDS_HETE | 7.24e-07 | 9 | 30 | 3 | M27143 | |
| Pathway | REACTOME_CYP2E1_REACTIONS | 1.42e-06 | 11 | 30 | 3 | M27130 | |
| Pathway | WP_OCTADECANOID_FORMATION_FROM_LINOLEIC_ACID | 1.89e-06 | 12 | 30 | 3 | M48064 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 2.46e-06 | 300 | 30 | 7 | M610 | |
| Pathway | WP_EICOSANOID_METABOLISM_VIA_CYTOCHROME_P450_MONOOXYGENASES | 3.12e-06 | 14 | 30 | 3 | MM15842 | |
| Pathway | KEGG_ARACHIDONIC_ACID_METABOLISM | 6.53e-06 | 58 | 30 | 4 | M5410 | |
| Pathway | WP_OXIDATION_BY_CYTOCHROME_P450 | 8.53e-06 | 62 | 30 | 4 | M39653 | |
| Pathway | REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE | 9.69e-06 | 64 | 30 | 4 | M5650 | |
| Pathway | KEGG_RETINOL_METABOLISM | 9.69e-06 | 64 | 30 | 4 | M9488 | |
| Pathway | WP_TAMOXIFEN_METABOLISM | 1.13e-05 | 21 | 30 | 3 | M39631 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 1.13e-05 | 21 | 30 | 3 | MM15706 | |
| Pathway | KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450 | 1.39e-05 | 70 | 30 | 4 | M16794 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 1.46e-05 | 258 | 30 | 6 | MM14572 | |
| Pathway | KEGG_DRUG_METABOLISM_CYTOCHROME_P450 | 1.55e-05 | 72 | 30 | 4 | M9257 | |
| Pathway | WP_ESTROGEN_METABOLISM_WP5276 | 1.71e-05 | 24 | 30 | 3 | M46445 | |
| Pathway | REACTOME_XENOBIOTICS | 1.94e-05 | 25 | 30 | 3 | MM14846 | |
| Pathway | REACTOME_BIOSYNTHESIS_OF_MARESIN_LIKE_SPMS | 6.53e-05 | 6 | 30 | 2 | M27909 | |
| Pathway | REACTOME_PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS | 6.61e-05 | 104 | 30 | 4 | M738 | |
| Pathway | WP_ARACHIDONATE_EPOXYGENASE_EPOXIDE_HYDROLASE | 9.13e-05 | 7 | 30 | 2 | M39515 | |
| Pathway | REACTOME_SYNTHESIS_OF_EPOXY_EET_AND_DIHYDROXYEICOSATRIENOIC_ACIDS_DHET | 9.13e-05 | 7 | 30 | 2 | MM14856 | |
| Pathway | REACTOME_ASPIRIN_ADME | 1.09e-04 | 44 | 30 | 3 | M45014 | |
| Pathway | REACTOME_NETRIN_1_SIGNALING | 1.09e-04 | 44 | 30 | 3 | M875 | |
| Pathway | REACTOME_BIOSYNTHESIS_OF_MARESINS | 1.22e-04 | 8 | 30 | 2 | M27891 | |
| Pathway | WP_EICOSANOID_METABOLISM_VIA_CYTOCHROME_P450_MONOOXYGENASES_PATHWAY | 1.56e-04 | 9 | 30 | 2 | M39819 | |
| Pathway | REACTOME_SYNTHESIS_OF_16_20_HYDROXYEICOSATETRAENOIC_ACIDS_HETE | 2.38e-04 | 11 | 30 | 2 | MM14863 | |
| Pathway | REACTOME_ARACHIDONIC_ACID_METABOLISM | 2.61e-04 | 59 | 30 | 3 | M27140 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | 2.74e-04 | 60 | 30 | 3 | MM15636 | |
| Pathway | REACTOME_CYP2E1_REACTIONS | 2.85e-04 | 12 | 30 | 2 | MM14847 | |
| Pathway | REACTOME_BIOSYNTHESIS_OF_MARESINS | 2.85e-04 | 12 | 30 | 2 | MM15616 | |
| Pathway | REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE | 3.64e-04 | 66 | 30 | 3 | MM14839 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 3.97e-04 | 68 | 30 | 3 | M27303 | |
| Pathway | REACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC | 5.16e-04 | 16 | 30 | 2 | M27410 | |
| Pathway | WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II | 5.78e-04 | 183 | 30 | 4 | M39588 | |
| Pathway | REACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS | 5.84e-04 | 17 | 30 | 2 | M27412 | |
| Pathway | REACTOME_BIOSYNTHESIS_OF_SPECIALIZED_PRORESOLVING_MEDIATORS_SPMS | 7.32e-04 | 19 | 30 | 2 | M27889 | |
| Pathway | REACTOME_BIOSYNTHESIS_OF_SPECIALIZED_PRORESOLVING_MEDIATORS_SPMS | 9.85e-04 | 22 | 30 | 2 | MM15614 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 1.08e-03 | 23 | 30 | 2 | M556 | |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | 1.15e-03 | 220 | 30 | 4 | M10320 | |
| Pathway | REACTOME_DECTIN_2_FAMILY | 1.38e-03 | 26 | 30 | 2 | M27483 | |
| Pathway | REACTOME_PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS | 1.41e-03 | 105 | 30 | 3 | MM14842 | |
| Pathway | REACTOME_DRUG_ADME | 1.57e-03 | 109 | 30 | 3 | M45012 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 1.57e-03 | 109 | 30 | 3 | MM15164 | |
| Pathway | WP_CANNABINOID_RECEPTOR_SIGNALING | 1.72e-03 | 29 | 30 | 2 | M39676 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 1.78e-03 | 114 | 30 | 3 | MM14571 | |
| Pathway | WP_CONSTITUTIVE_ANDROSTANE_RECEPTOR_PATHWAY | 1.96e-03 | 31 | 30 | 2 | M39476 | |
| Pathway | WP_PREGNANE_X_RECEPTOR_PATHWAY | 2.09e-03 | 32 | 30 | 2 | M39567 | |
| Pathway | KEGG_AXON_GUIDANCE | 2.54e-03 | 129 | 30 | 3 | M5539 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 3.20e-03 | 140 | 30 | 3 | M587 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 3.40e-03 | 143 | 30 | 3 | M27275 | |
| Pathway | REACTOME_ASPIRIN_ADME | 4.09e-03 | 45 | 30 | 2 | MM15694 | |
| Pathway | REACTOME_FATTY_ACID_METABOLISM | 6.06e-03 | 176 | 30 | 3 | M27854 | |
| Pubmed | 2.68e-12 | 4 | 46 | 4 | 2009263 | ||
| Pubmed | 2.68e-12 | 4 | 46 | 4 | 21798861 | ||
| Pubmed | Biochemistry and molecular biology of the human CYP2C subfamily. | 2.68e-12 | 4 | 46 | 4 | 7704034 | |
| Pubmed | 2.68e-12 | 4 | 46 | 4 | 23755828 | ||
| Pubmed | 2.68e-12 | 4 | 46 | 4 | 19706858 | ||
| Pubmed | 2.17e-09 | 3 | 46 | 3 | 28687336 | ||
| Pubmed | The human CYP2C locus: a prototype for intergenic and exon repetition splicing events. | 2.17e-09 | 3 | 46 | 3 | 10704292 | |
| Pubmed | A 2.4-megabase physical map spanning the CYP2C gene cluster on chromosome 10q24. | 2.17e-09 | 3 | 46 | 3 | 8530044 | |
| Pubmed | 2.17e-09 | 3 | 46 | 3 | 21173785 | ||
| Pubmed | 2.17e-09 | 3 | 46 | 3 | 15102943 | ||
| Pubmed | 2.17e-09 | 3 | 46 | 3 | 35134542 | ||
| Pubmed | 2.17e-09 | 3 | 46 | 3 | 24430292 | ||
| Pubmed | Distribution of CYP2C polymorphisms in an Amerindian population of Brazil. | 2.17e-09 | 3 | 46 | 3 | 21977947 | |
| Pubmed | 2.17e-09 | 3 | 46 | 3 | 20665013 | ||
| Pubmed | 2.17e-09 | 3 | 46 | 3 | 27803446 | ||
| Pubmed | Characterisation of CYP2C8, CYP2C9 and CYP2C19 polymorphisms in a Ghanaian population. | 2.17e-09 | 3 | 46 | 3 | 19954515 | |
| Pubmed | 2.17e-09 | 3 | 46 | 3 | 23464473 | ||
| Pubmed | 2.17e-09 | 3 | 46 | 3 | 8095407 | ||
| Pubmed | 2.17e-09 | 3 | 46 | 3 | 23118231 | ||
| Pubmed | Novel DNA sequence variations of cytochrome P450 genes in the Han Chinese population. | 2.65e-09 | 14 | 46 | 4 | 19290787 | |
| Pubmed | Association of warfarin dose with genes involved in its action and metabolism. | 4.82e-09 | 16 | 46 | 4 | 17048007 | |
| Pubmed | Polymorphism of CYP2D6, CYP2C19, CYP2C9 and CYP2C8 in the Faroese population. | 8.65e-09 | 4 | 46 | 3 | 16025294 | |
| Pubmed | 8.65e-09 | 4 | 46 | 3 | 28990182 | ||
| Pubmed | Molecular genetics of the human cytochrome P450 monooxygenase superfamily. | 1.28e-08 | 20 | 46 | 4 | 9890157 | |
| Pubmed | Prevalence of CYP450 gene variations in patients with type 2 diabetes. | 2.16e-08 | 5 | 46 | 3 | 20857895 | |
| Pubmed | Polymorphism of human mucin genes in chest disease: possible significance of MUC2. | 2.16e-08 | 5 | 46 | 3 | 11062147 | |
| Pubmed | 2.16e-08 | 5 | 46 | 3 | 19415824 | ||
| Pubmed | MUC1, MUC2, MUC4, MUC5AC and MUC6 expression in the progression of prostate cancer. | 2.16e-08 | 5 | 46 | 3 | 16475027 | |
| Pubmed | A genome-wide association study of acenocoumarol maintenance dosage. | 4.32e-08 | 6 | 46 | 3 | 19578179 | |
| Pubmed | Genetic polymorphism of cytochrome P450s and P-glycoprotein in the Finnish population. | 4.32e-08 | 6 | 46 | 3 | 17635176 | |
| Pubmed | 7.16e-08 | 30 | 46 | 4 | 20529763 | ||
| Pubmed | 2.58e-07 | 10 | 46 | 3 | 19651758 | ||
| Pubmed | 2.58e-07 | 10 | 46 | 3 | 20602612 | ||
| Pubmed | 3.55e-07 | 11 | 46 | 3 | 15039299 | ||
| Pubmed | Genetic variation in eleven phase I drug metabolism genes in an ethnically diverse population. | 3.55e-07 | 11 | 46 | 3 | 15469410 | |
| Pubmed | 4.72e-07 | 12 | 46 | 3 | 15319333 | ||
| Pubmed | 7.80e-07 | 14 | 46 | 3 | 20970553 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 7574697 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 17203232 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 16198656 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 30562214 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 26122864 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 24288737 | ||
| Pubmed | [Association between genetic polymorphisms of CYP2C19 and CYP2C9 and phenytoin serum concentration]. | 1.71e-06 | 2 | 46 | 2 | 15569425 | |
| Pubmed | Multi-ethnic distribution of clinically relevant CYP2C genotypes and haplotypes. | 1.71e-06 | 2 | 46 | 2 | 22491019 | |
| Pubmed | MUC4 and MUC5AC are highly specific tumour-associated mucins in biliary tract cancer. | 1.71e-06 | 2 | 46 | 2 | 18475301 | |
| Pubmed | Linkage between the CYP2C8 and CYP2C9 genetic polymorphisms. | 1.71e-06 | 2 | 46 | 2 | 12435384 | |
| Pubmed | Important amino acid residues that confer CYP2C19 selective activity to CYP2C9. | 1.71e-06 | 2 | 46 | 2 | 18511451 | |
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 28686288 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 18694831 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 20808793 | ||
| Pubmed | Methylation status of promoters and expression of MUC2 and MUC5AC mucins in pancreatic cancer cells. | 1.71e-06 | 2 | 46 | 2 | 12527922 | |
| Pubmed | Developmental expression of human hepatic CYP2C9 and CYP2C19. | 1.71e-06 | 2 | 46 | 2 | 14634042 | |
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 22918969 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 15606441 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 32567426 | ||
| Pubmed | CYP2C40, a unique arachidonic acid 16-hydroxylase, is the major CYP2C in murine intestinal tract. | 1.71e-06 | 2 | 46 | 2 | 10908295 | |
| Pubmed | Role of CYP2C9 and CYP2C19 polymorphisms in patients with atherosclerosis. | 1.71e-06 | 2 | 46 | 2 | 17868191 | |
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 32868386 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 19432394 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 27617498 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 1847130 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 16873909 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 28513222 | ||
| Pubmed | Cytochromes P450 catalyze oxidation of alpha,beta-unsaturated aldehydes. | 1.71e-06 | 2 | 46 | 2 | 17599801 | |
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 19038035 | ||
| Pubmed | Evidence that CYP2C19 is the major (S)-mephenytoin 4'-hydroxylase in humans. | 1.71e-06 | 2 | 46 | 2 | 8110777 | |
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 106274 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 15385837 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 25518510 | ||
| Pubmed | Gene structure and upstream regulatory regions of human CYP2C9 and CYP2C18. | 1.71e-06 | 2 | 46 | 2 | 8333835 | |
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 16372821 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 15776277 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 15842554 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 24492587 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 19136640 | ||
| Pubmed | Mouse Cyp2c expression and zonation structure in the liver begins in the early neonatal stage. | 1.71e-06 | 2 | 46 | 2 | 35748067 | |
| Pubmed | Phase I pharmacokinetic and pharmacogenomic study of E7070 administered once every 21 days. | 1.71e-06 | 2 | 46 | 2 | 16232205 | |
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 20890775 | ||
| Pubmed | The clinically relevant CYP2C8*3 and CYP2C9*2 haplotype is inherited from Neandertals. | 1.71e-06 | 2 | 46 | 2 | 35780191 | |
| Pubmed | Time serial transcriptome reveals Cyp2c29 as a key gene in hepatocellular carcinoma development. | 1.71e-06 | 2 | 46 | 2 | 32587777 | |
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 20845310 | ||
| Pubmed | Genetic polymorphisms of cytochrome P450 enzymes 2C9 and 2C19 in a healthy Iranian population. | 1.71e-06 | 2 | 46 | 2 | 17201743 | |
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 32683556 | ||
| Pubmed | Relationship between CYP2C8 genotypes and diclofenac 5-hydroxylation in healthy Spanish volunteers. | 1.71e-06 | 2 | 46 | 2 | 18548238 | |
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 18216720 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 15855721 | ||
| Pubmed | Cloning and expression of murine CYP2Cs and their ability to metabolize arachidonic acid. | 1.71e-06 | 2 | 46 | 2 | 9721182 | |
| Pubmed | Genetic variance in CYP2C8 and increased risk of myocardial infarction. | 1.71e-06 | 2 | 46 | 2 | 20436375 | |
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 19847408 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 17321686 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 17504998 | ||
| Pubmed | Cytochrome P450 2C epoxygenases mediate photochemical stress-induced death of photoreceptors. | 1.71e-06 | 2 | 46 | 2 | 24519941 | |
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 14623888 | ||
| Pubmed | Altered expression of MUC2 and MUC5AC in progression of colorectal carcinoma. | 1.71e-06 | 2 | 46 | 2 | 20731025 | |
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 7841444 | ||
| Pubmed | Cytochrome P450 polymorphisms in patients with Behcet's disease. | 1.71e-06 | 2 | 46 | 2 | 17269966 | |
| Pubmed | Allelic variants of cytochromes P450 2C modify the risk for acute myocardial infarction. | 1.71e-06 | 2 | 46 | 2 | 14646690 | |
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 17627038 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 11950794 | ||
| Interaction | CYP2C19 interactions | 9.02e-08 | 5 | 43 | 3 | int:CYP2C19 | |
| Interaction | CYP2C18 interactions | 3.04e-07 | 27 | 43 | 4 | int:CYP2C18 | |
| Cytoband | 10q24 | 6.02e-06 | 35 | 46 | 3 | 10q24 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr10q23 | 4.48e-05 | 195 | 46 | 4 | chr10q23 | |
| Cytoband | 1p36.21 | 1.84e-03 | 63 | 46 | 2 | 1p36.21 | |
| GeneFamily | Cytochrome P450 family 2 | 4.63e-07 | 35 | 33 | 4 | 1001 | |
| GeneFamily | CD molecules|Mucins | 7.20e-06 | 21 | 33 | 3 | 648 | |
| GeneFamily | PRAME family | 8.70e-04 | 24 | 33 | 2 | 686 | |
| GeneFamily | C2-set domain containing|Immunoglobulin like domain containing|Scavenger receptors | 1.10e-03 | 27 | 33 | 2 | 1253 | |
| Coexpression | NABA_CORE_MATRISOME | 9.03e-10 | 270 | 46 | 9 | MM17057 | |
| Coexpression | NABA_CORE_MATRISOME | 1.06e-09 | 275 | 46 | 9 | M5884 | |
| Coexpression | NABA_MATRISOME | COL2A1 KCP VWC2 NTN4 OTOL1 ADAM19 CRIM1 MUC2 LTBP4 MUC4 MUC5AC SPOCK3 IGFBPL1 SLIT3 | 1.08e-09 | 1008 | 46 | 14 | MM17056 |
| Coexpression | NABA_MATRISOME | COL2A1 KCP VWC2 NTN4 OTOL1 ADAM19 CRIM1 MUC2 LTBP4 MUC4 MUC5AC SPOCK3 IGFBPL1 SLIT3 | 1.35e-09 | 1026 | 46 | 14 | M5889 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 4.11e-08 | 191 | 46 | 7 | MM17059 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 4.91e-08 | 196 | 46 | 7 | M3008 | |
| Coexpression | SAENZ_DETOX_PATHWAY_AND_CARCINOGENESIS_DN | 5.65e-06 | 20 | 46 | 3 | MM1104 | |
| Coexpression | MARTENS_TRETINOIN_RESPONSE_UP | SCARF1 ZSCAN1 CELSR2 MUC2 MUC4 ITGB2 IGFBPL1 TNFRSF14 LRRC26 | 1.49e-05 | 855 | 46 | 9 | M2098 |
| Coexpression | WENG_POR_DOSAGE | 1.99e-05 | 30 | 46 | 3 | MM1199 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_DN | 2.35e-05 | 95 | 46 | 4 | M1111 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_DN | 3.23e-05 | 103 | 46 | 4 | MM476 | |
| Coexpression | WIEMANN_TELOMERE_SHORTENING_AND_CHRONIC_LIVER_DAMAGE_DN | 4.50e-05 | 6 | 46 | 2 | MM971 | |
| Coexpression | CAIRO_HEPATOBLASTOMA_DN | 1.03e-04 | 267 | 46 | 5 | M13449 | |
| Coexpression | DESCARTES_FETAL_INTESTINE_INTESTINAL_EPITHELIAL_CELLS | 1.26e-04 | 279 | 46 | 5 | M40212 | |
| Coexpression | KRAS.600_UP.V1_DN | 1.26e-04 | 279 | 46 | 5 | M2880 | |
| Coexpression | CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_3 | 2.54e-04 | 726 | 46 | 7 | M4210 | |
| Coexpression | BUSSLINGER_DUODENAL_PANETH_CELLS | 3.12e-04 | 15 | 46 | 2 | M40030 | |
| Coexpression | SAENZ_DETOX_PATHWAY_AND_CARCINOGENESIS_DN | 3.12e-04 | 15 | 46 | 2 | M1141 | |
| Coexpression | CYCLIN_D1_UP.V1_UP | 3.24e-04 | 187 | 46 | 4 | M2654 | |
| Coexpression | BUSSLINGER_DUODENAL_GOBLET_CELLS | 3.56e-04 | 16 | 46 | 2 | M40031 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_SMG_CELL | 3.77e-04 | 775 | 46 | 7 | M45713 | |
| Coexpression | GSE9006_TYPE_1_DIABETES_AT_DX_VS_4MONTH_POST_DX_PBMC_DN | 3.80e-04 | 195 | 46 | 4 | M5788 | |
| Coexpression | KOHOUTEK_CCNT2_TARGETS | 3.92e-04 | 81 | 46 | 3 | MM938 | |
| Coexpression | GSE1460_DP_THYMOCYTE_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_DN | 3.95e-04 | 197 | 46 | 4 | M3465 | |
| Coexpression | GSE22527_ANTI_CD3_INVIVO_VS_UNTREATED_MOUSE_TREG_UP | 4.10e-04 | 199 | 46 | 4 | M7710 | |
| Coexpression | GSE4984_GALECTIN1_VS_VEHICLE_CTRL_TREATED_DC_DN | 4.10e-04 | 199 | 46 | 4 | M6507 | |
| Coexpression | GSE4142_GC_BCELL_VS_MEMORY_BCELL_UP | 4.18e-04 | 200 | 46 | 4 | M6397 | |
| Coexpression | GSE39556_UNTREATED_VS_3H_POLYIC_INJ_MOUSE_NK_CELL_DN | 4.18e-04 | 200 | 46 | 4 | M9411 | |
| Coexpression | GSE8921_UNSTIM_0H_VS_TLR1_2_STIM_MONOCYTE_6H_DN | 4.18e-04 | 200 | 46 | 4 | M6404 | |
| Coexpression | GSE8921_UNSTIM_0H_VS_TLR1_2_STIM_MONOCYTE_12H_DN | 4.18e-04 | 200 | 46 | 4 | M6408 | |
| Coexpression | GSE8685_IL2_STARVED_VS_IL15_ACT_IL2_STARVED_CD4_TCELL_DN | 4.18e-04 | 200 | 46 | 4 | M327 | |
| Coexpression | JONES_OVARY_NK_CELL | 5.17e-04 | 89 | 46 | 3 | M48353 | |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial-Epi_airway_secretory-Secretory_Goblet|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.33e-09 | 198 | 46 | 7 | 5dd2aa7684c36beffa204ca4c04d0501cabac10f | |
| ToppCell | 356C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.62e-08 | 175 | 46 | 6 | af9c5104c86231cfdb93a0f7d7032379efaa009e | |
| ToppCell | 356C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.62e-08 | 175 | 46 | 6 | 4bfae78ac3a2cb9404382aae96d291504a9cfa14 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-goblet-BEST2+_Goblet_cell|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.99e-08 | 179 | 46 | 6 | c833ded1f9e87be2ba2037820d92a389560b711c | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Epithelial-goblet-Goblet_cell|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.45e-08 | 198 | 46 | 6 | f95f38cc747fb3549a791288bf8d0518c049ac96 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Epithelial-goblet|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.45e-08 | 198 | 46 | 6 | 9c5d7852f03468394e726c444cac92a043fc6d0e | |
| ToppCell | Biopsy_Control_(H.)-Epithelial-MUC5AC+_High|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 5.61e-08 | 199 | 46 | 6 | a5240868cea40574ed4ee45eb27a00c1812957ed | |
| ToppCell | NS-critical-d_0-4-Epithelial-Secretory-diff|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.78e-08 | 200 | 46 | 6 | 047e00f31ca744f82d61cac0e4e66563381f214b | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Hematologic-fibroblast|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.53e-07 | 169 | 46 | 5 | 15a9183c838cc6384d7f5dfeae3d30602964c9b3 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.07e-06 | 177 | 46 | 5 | 709235694cc711b9b79690e23c94577b2ae06811 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.07e-06 | 177 | 46 | 5 | 7f9c2a45a994b32f15e5693f7cb873716a4eb568 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.13e-06 | 179 | 46 | 5 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.13e-06 | 179 | 46 | 5 | 859cd8ee414ad6207c046ada2e655e49322dd01c | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular-Goblet|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.16e-06 | 180 | 46 | 5 | 3dc80bc636bf0e6ffc9762853132a9fe59fd1f66 | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular-Goblet-Goblet|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.16e-06 | 180 | 46 | 5 | 668a2d8e1d5a390309d5eb62c836f5903144bea9 | |
| ToppCell | Control-Epithelial_cells-Airway_goblet|Control / group, cell type (main and fine annotations) | 1.30e-06 | 184 | 46 | 5 | d92a71441e4e19f8c301999d8186f8e48e3cd162 | |
| ToppCell | IPF-Myeloid-DC_Langerhans|Myeloid / Disease state, Lineage and Cell class | 1.33e-06 | 185 | 46 | 5 | ced17f69486591c3cbbdc852a3e82c3f3a4a30d7 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.44e-06 | 188 | 46 | 5 | 5901b276f2379abf486b8285957277e95f08464e | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.56e-06 | 191 | 46 | 5 | 529068029fb461df766135576dd0d8b5980f9bc0 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-goblet|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.64e-06 | 193 | 46 | 5 | 402aad2f9e789ad1f2e1536cdc9ce61de7625427 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-goblet-Goblet_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.64e-06 | 193 | 46 | 5 | 7ee3b1ef5c455f321b4e154ae62c69543fe9b30e | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-goblet-Goblet_cell|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.68e-06 | 194 | 46 | 5 | 49cc5f5de4380302100e8cd937f08abe317ac75e | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-goblet|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.68e-06 | 194 | 46 | 5 | fb935df966c451e659b8bde281f8aebcb632f6cf | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-goblet-Goblet_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.72e-06 | 195 | 46 | 5 | 7ff04c45a02df01e3816f3c1d43585a93182a730 | |
| ToppCell | NS-critical-LOC-Epithelial-Secretory|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.72e-06 | 195 | 46 | 5 | b0d782eeee30c797b4da9b3be29b864983fd9e71 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-goblet|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.72e-06 | 195 | 46 | 5 | 09605533aa5947bb2e5a6725c1ce89f79d330bf5 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-goblet|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.77e-06 | 196 | 46 | 5 | c2d17630f7bfc9e727de55e093c17fddac61b61f | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-goblet-Goblet_cell|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.77e-06 | 196 | 46 | 5 | 54c30023d04e7265373647f56fc93885804938b0 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.90e-06 | 199 | 46 | 5 | 1e693d7bb481bf03a943b460a69787229625d7b1 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_secretory|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.90e-06 | 199 | 46 | 5 | a706ad5cd5e0dc8d7e925a05e45b07d35963f294 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Secretory-diff|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.95e-06 | 200 | 46 | 5 | 8f179b5768fd504af6dd6f6749a0bed7b689e77f | |
| ToppCell | critical-Epithelial-Secretory-diff|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.95e-06 | 200 | 46 | 5 | 407465404c5818bd2cd9d489bfbf29c3a55429d4 | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Undifferentiated_Pleomorphic_Sarcoma-4|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 1.02e-05 | 131 | 46 | 4 | 2ccf679b5035b7b9cdb9a9a660cad90288592187 | |
| ToppCell | TCGA-Bile_Duct|World / Sample_Type by Project: Shred V9 | 1.32e-05 | 140 | 46 | 4 | ca8a0ccbc2f501b759864fe9bb06dc8b44b6b31f | |
| ToppCell | Club_cells-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 2.29e-05 | 161 | 46 | 4 | bd08a23b415617f6e8748ed2668d578a860ecf91 | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-myeloid-myeloid_dendritic|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.35e-05 | 162 | 46 | 4 | 233011408f022647932c81ebab78f9813e3c6833 | |
| ToppCell | 5'-Adult-Appendix-Epithelial-goblet-BEST2+_Goblet_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.46e-05 | 164 | 46 | 4 | 29da0175bd3808a5b3039a6161c764105608ef96 | |
| ToppCell | 5'-Adult-Appendix-Epithelial-goblet|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.46e-05 | 164 | 46 | 4 | e83b632ac7e1dace946991ddfe1fbfbbffc3a88b | |
| ToppCell | lung-Club_Cells|lung / shred on tissue and cell subclass | 2.46e-05 | 164 | 46 | 4 | b12cacd499b18b96120ca6d14646aebeaed41d10 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-epithelial_progenitor_cell-Distal_progenitor|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.46e-05 | 164 | 46 | 4 | d6f71d804bb65301c02ea4e6673e20688b5fcd5b | |
| ToppCell | facs-Kidney-nan-3m-Lymphocytic-B_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.58e-05 | 166 | 46 | 4 | 6a948aefd283a2572da37b59dbc142b6e686b024 | |
| ToppCell | facs-Kidney-nan-3m-Lymphocytic-B_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.58e-05 | 166 | 46 | 4 | 8d0c4eb90a2c006f96ae61d3d94c96fb64bc0c4d | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)-Club_(non-nasal)_L.0.4.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.58e-05 | 166 | 46 | 4 | 9e98e6070055bfc780becee52d77830e06b6d854 | |
| ToppCell | Adult-Epithelial-lung_goblet_cell-D122|Adult / Lineage, Cell type, age group and donor | 2.65e-05 | 167 | 46 | 4 | 6efbb2ef6adc8da5dd67210969f825f5cc8ed022 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l34|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.65e-05 | 167 | 46 | 4 | 102b3d160a44c8623fab1fd10e9054178c42a78b | |
| ToppCell | 3'-Adult-LargeIntestine-Epithelial-goblet-Goblet_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.71e-05 | 168 | 46 | 4 | 2163e6774eb7a3d010422e4d59be5e45b4158329 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)-Goblet_(bronchial)_L.0.4.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.77e-05 | 169 | 46 | 4 | db73dae011ff3749b3706e50ab46d03b775dd6bb | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.77e-05 | 169 | 46 | 4 | 97b7047b87ce0052d8580565c9b44fd2aa6f0d5c | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.77e-05 | 169 | 46 | 4 | 1a684471dbda42e1470e5a889648666e14f25982 | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-goblet-Goblet_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.90e-05 | 171 | 46 | 4 | 48125d825ca2d7ef34564250f5b47d2a579e03c9 | |
| ToppCell | 11.5-Airway-Epithelial-Basal_cell|Airway / Age, Tissue, Lineage and Cell class | 2.97e-05 | 172 | 46 | 4 | 9d4d92e2d16dfc8a394f2641653bb97de20a2530 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Epithelial-goblet|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.11e-05 | 174 | 46 | 4 | e7cca4b6a3935fad61cf2a3d9984ab1ffa1a9447 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Epithelial-goblet-Goblet_cell|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.11e-05 | 174 | 46 | 4 | ad5b56f0ace6455c033834b931ec870cc0dc9290 | |
| ToppCell | 5'-Adult-Distal_Rectal-Epithelial-goblet-BEST2+_Goblet_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.18e-05 | 175 | 46 | 4 | 019ea30ac55748463d7917abf3d3f0e804189bfd | |
| ToppCell | 5'-Adult-Distal_Rectal-Epithelial-goblet-Goblet_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.32e-05 | 177 | 46 | 4 | e1e45956887371b1c18f1eb479dd930031497520 | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Secretory/RAS|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.32e-05 | 177 | 46 | 4 | 779ba86f53650772755b52460be03f18bb204e55 | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Secretory/RAS-Secretory|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.32e-05 | 177 | 46 | 4 | 0f210cfb61b873c5fd77dc17eadf4d017306500e | |
| ToppCell | 5'-Adult-Distal_Rectal-Epithelial-goblet|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.39e-05 | 178 | 46 | 4 | 9099b47e0756d6a1b7ba1c6aa7b47c5425f649e0 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Endothelial-endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.55e-05 | 180 | 46 | 4 | 2405aa5699a8d8cf4c6b3dca07510e774728ac50 | |
| ToppCell | Ciliated_cells-A-Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 3.55e-05 | 180 | 46 | 4 | d9be152773fe9f2160edad9246fa03c03afeafd6 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Endothelial-Endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.55e-05 | 180 | 46 | 4 | 9c47852c0a723e2f5cd6898afff4c31a0da06905 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Endothelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.55e-05 | 180 | 46 | 4 | 499d5fe71e0dc20cffdf85e3b3f14eb4e83e3a3d | |
| ToppCell | droplet-Liver-nan-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.62e-05 | 181 | 46 | 4 | a53f05c4c47465ee62e353716456bd09ab464b23 | |
| ToppCell | IPF-Myeloid-DC_Langerhans|World / Disease state, Lineage and Cell class | 3.70e-05 | 182 | 46 | 4 | 0e8cfbd8ea196f27a227dbb4d2eb93bc48d27922 | |
| ToppCell | facs-Kidney-nan-24m-Epithelial-kidney_loop_of_Henle_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.70e-05 | 182 | 46 | 4 | b8be66a867ea1bbae0820b26dbd55b68611f5ad5 | |
| ToppCell | facs-Kidney-nan-24m-Epithelial-kidney_loop_of_Henle_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.70e-05 | 182 | 46 | 4 | cb488f9a9b200e2557335ccf22535cd247512cdc | |
| ToppCell | droplet-Liver-nan-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.78e-05 | 183 | 46 | 4 | 709a486154b3157427deb3b8886b63ac39ea42dd | |
| ToppCell | droplet-Liver-nan-3m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.78e-05 | 183 | 46 | 4 | dc06f19f6f80f4c7f13f1f990c1fe0f91ba64ea7 | |
| ToppCell | Dendritic_Cells-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 3.78e-05 | 183 | 46 | 4 | dd09e39e8ca282ff0f470e0652d519e190badd0b | |
| ToppCell | Control-Epithelial_cells-Airway_mucous|Control / group, cell type (main and fine annotations) | 3.78e-05 | 183 | 46 | 4 | 15d24a4fb1ffe6cbafbd54fcd7dde9ddcfbe03b2 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Epithelial-goblet-Goblet_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.86e-05 | 184 | 46 | 4 | 886d2d9bf2fe31207f17e3edc309ef44029924e1 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Epithelial-goblet|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.86e-05 | 184 | 46 | 4 | 936b39377eebea3961d702532779f6cd27953be7 | |
| ToppCell | IPF-Myeloid-DC_Langerhans|IPF / Disease state, Lineage and Cell class | 3.95e-05 | 185 | 46 | 4 | f8ee3cb2aa9ec70f9ce8797be2b155da27ef6464 | |
| ToppCell | droplet-Heart-nan-18m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.95e-05 | 185 | 46 | 4 | a32d5cb596ebac80eb1ac301055e65d420879ec8 | |
| ToppCell | droplet-Pancreas-Exocrine-24m-Endothelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.11e-05 | 187 | 46 | 4 | a178b1fed80a0bf83aedb6262493ee17374734b5 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.11e-05 | 187 | 46 | 4 | 71d99a1a95d3692a2891da49d4a243bae6e07fd0 | |
| ToppCell | droplet-Pancreas-Exocrine-24m-Endothelial-endothelial_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.11e-05 | 187 | 46 | 4 | e60cbccf5842f25123fd34b9475759b7424b32e9 | |
| ToppCell | droplet-Pancreas-Exocrine-24m-Endothelial-endothelial_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.11e-05 | 187 | 46 | 4 | 2b8eda2812be0be68a6f01aa4038925d3d5b1e65 | |
| ToppCell | LAM-Myeloid-DC|LAM / Condition, Lineage and Cell class | 4.20e-05 | 188 | 46 | 4 | b4140110c2f7d25fd8a0d2749e33e02003ac4bf2 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-G_(Club-Clara_cells)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 4.29e-05 | 189 | 46 | 4 | b06471b1bebb990d5146bddfb8002401c6b099a0 | |
| ToppCell | facs-Trachea-24m-Epithelial-airway_epithelial-respiratory_basal_cell-basal_epithelial_cell_of_trachea|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.29e-05 | 189 | 46 | 4 | ee15b4fb3a1cfda80bcf210a23f04f242594015e | |
| ToppCell | facs-Trachea-24m-Epithelial-airway_epithelial-respiratory_basal_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.29e-05 | 189 | 46 | 4 | dc6f6fae84347d145bea71b49eaeeb3028e9c4ae | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Endothelial-endothelial_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.29e-05 | 189 | 46 | 4 | 8ced0381ea042ba47680a02b617a2368fa2c54c8 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-G_(Club-Clara_cells)|343B / Donor, Lineage, Cell class and subclass (all cells) | 4.29e-05 | 189 | 46 | 4 | a8246acf31f02c85421268245afb651aa8788f14 | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Endothelial|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.29e-05 | 189 | 46 | 4 | 403a82bb416aed13b9d31411ad17bdc4ce2a95fb | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.38e-05 | 190 | 46 | 4 | a08c5929b05a4969852e351a93c4e4deb4c8d5b6 | |
| ToppCell | (2)_5-FU-(1)_VE-Cad+_vascular_cells|World / Stress and Cell class | 4.38e-05 | 190 | 46 | 4 | 6b391b8a3ffcbdec3acaf242bc52fc3fc9da77c8 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Artery|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.38e-05 | 190 | 46 | 4 | aed65d584ca0c25f6a8313c66b421a6618af82ea | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Endothelial-endothelial_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.38e-05 | 190 | 46 | 4 | 38a815abf0ac5cac6071737cadc54a514f62d37d | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.38e-05 | 190 | 46 | 4 | 25525fee1da8a808034d9c916159fd0b6b26bce8 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Endothelial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.38e-05 | 190 | 46 | 4 | bb1476b44dd49e1dd52a636a91c4600b6d4fbe2e | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Endothelial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.38e-05 | 190 | 46 | 4 | d180205c70b5ca9bc5a01a2e6cb42fcebc7f630d | |
| ToppCell | Club|World / shred by cell class for parenchyma | 4.38e-05 | 190 | 46 | 4 | 1974d559d7fee6cb68065b18af8bd38b64910622 | |
| ToppCell | (7)_Epithelial-G_(Club-Clara_cells)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 4.38e-05 | 190 | 46 | 4 | 593fd1451038b155826a48de4caa38f44406d0b9 | |
| ToppCell | droplet-Lung-1m-Endothelial-venous_endothelial|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.56e-05 | 192 | 46 | 4 | 1990dc8a81594018a5bf596be99d0b5f0af0f58f | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.56e-05 | 192 | 46 | 4 | 2bfac6b3956265205ca47d06888851ed68b65999 | |
| ToppCell | (7)_Epithelial_cells-(7)_Epithelial-G_(Club-Clara_cells)|(7)_Epithelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 4.56e-05 | 192 | 46 | 4 | c7c232545fad8ad327ab94bd0def8dc5daacd03d | |
| ToppCell | PCW_07-8.5-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_proliferating_myeloid_(8)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.56e-05 | 192 | 46 | 4 | 7e7383093efaadceadd4d1f900c2d39cd690102e | |
| ToppCell | droplet-Lung-1m-Endothelial-venous_endothelial-vein_endothelial_cell-vein_endothelial_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.56e-05 | 192 | 46 | 4 | 845cc9c18b4436b07dd3ce7980052683937546d2 | |
| ToppCell | droplet-Lung-1m-Endothelial-venous_endothelial-vein_endothelial_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.56e-05 | 192 | 46 | 4 | c72a082c93a8825adbfef37f889ba3a7052f201b | |
| Computational | Cytochrome P450. | 4.84e-08 | 14 | 30 | 4 | MODULE_106 | |
| Computational | Genes in the cancer module 135. | 4.33e-05 | 25 | 30 | 3 | MODULE_135 | |
| Computational | Heart, liver, kidney and pancreas metabolic and xenobiotic response genes. | COL2A1 ABLIM1 CYP2C19 CYP2C8 ADAM19 FCGBP CRIM1 STARD5 TNFRSF14 STAB1 | 5.42e-05 | 835 | 30 | 10 | MODULE_88 |
| Computational | Thymus genes. | 2.34e-04 | 325 | 30 | 6 | MODULE_44 | |
| Computational | Genes in the cancer module 55. | COL2A1 ABLIM1 CYP2C19 CYP2C8 ADAM19 CRIM1 STARD5 TNFRSF14 STAB1 | 3.09e-04 | 832 | 30 | 9 | MODULE_55 |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 3.52e-04 | 50 | 30 | 3 | GAVISH_3CA_METAPROGRAM_EPITHELIAL_COLON_RELATED | |
| Computational | Liver genes - metabolism and xenobiotics. | 7.38e-04 | 563 | 30 | 7 | MODULE_23 | |
| Computational | Trachea genes. | 8.62e-04 | 415 | 30 | 6 | MODULE_6 | |
| Computational | Lung genes. | 1.09e-03 | 434 | 30 | 6 | MODULE_5 | |
| Computational | Neighborhood of ERCC4 | 1.77e-03 | 321 | 30 | 5 | MORF_ERCC4 | |
| Computational | Neighborhood of IGF1 | 2.35e-03 | 26 | 30 | 2 | GNF2_IGF1 | |
| Drug | 4',5-dihydroxydiclofenac | 1.81e-10 | 6 | 44 | 4 | CID003052567 | |
| Drug | 3'-hydroxydiclofenac | 1.81e-10 | 6 | 44 | 4 | CID000112230 | |
| Drug | 5-hydroxydiclofenac | 5.94e-09 | 12 | 44 | 4 | CID003052566 | |
| Drug | 4-hydroxyretinoic acid | 5.94e-09 | 12 | 44 | 4 | ctd:C019429 | |
| Drug | 2'-(glutathion-S-yl)-deschlorodiclofenac | 1.63e-08 | 15 | 44 | 4 | ctd:C586542 | |
| Drug | Azamulinum | 3.64e-08 | 18 | 44 | 4 | CID003086060 | |
| Drug | D 703 | 3.64e-08 | 18 | 44 | 4 | CID000054088 | |
| Drug | hydroxytolbutamide | 4.60e-08 | 19 | 44 | 4 | CID000003656 | |
| Drug | 3C etc | 5.74e-08 | 20 | 44 | 4 | CID000164045 | |
| Drug | bufuralol | 6.72e-08 | 5 | 44 | 3 | ctd:C010831 | |
| Drug | 4,4'-cyclohexylidenebisphenol | 1.34e-07 | 6 | 44 | 3 | ctd:C570106 | |
| Drug | AC1O5Z5L | 1.34e-07 | 6 | 44 | 3 | CID006443527 | |
| Drug | Tolbutamide | 1.49e-07 | 25 | 44 | 4 | ctd:D014044 | |
| Drug | 1,4-naphthoquinone | 1.76e-07 | 26 | 44 | 4 | ctd:C035342 | |
| Drug | 5-fluorotryptamine | 2.34e-07 | 7 | 44 | 3 | ctd:C034536 | |
| Drug | 6-Fluoro-6-desoxyoxymorphone | 2.34e-07 | 7 | 44 | 3 | CID005486899 | |
| Drug | 16-O-demethylaconitine | 2.34e-07 | 7 | 44 | 3 | ctd:C486136 | |
| Drug | (hydrochloride) | 2.78e-07 | 29 | 44 | 4 | CID000004923 | |
| Drug | 13-hydroxyeicosatetraenoic acid | 3.75e-07 | 8 | 44 | 3 | CID006439499 | |
| Drug | 11-HODE | 3.75e-07 | 8 | 44 | 3 | CID006438497 | |
| Drug | 5-bromotryptamine | 3.75e-07 | 8 | 44 | 3 | ctd:C040997 | |
| Drug | 1-(3-(4-phenoxyphenoxy)-2-oxopropyl)indole-5-carboxylic acid | 3.75e-07 | 8 | 44 | 3 | ctd:C585955 | |
| Drug | BP-7,8-oxide | 4.19e-07 | 32 | 44 | 4 | CID000037455 | |
| Drug | 4,5-dihydropyrazole-1,5-dicarboxylic acid 1-((4-chlorophenyl)-amide) 5-(2-oxo-2H-(1,3')bipyridinyl-6'-yl)-amide | 5.61e-07 | 9 | 44 | 3 | ctd:C545880 | |
| Drug | Acenocoumarol | 5.61e-07 | 9 | 44 | 3 | ctd:D000074 | |
| Drug | 5-chlorotryptamine | 5.61e-07 | 9 | 44 | 3 | ctd:C529169 | |
| Drug | 3-(2-(4-(3-chloro-2-methylphenyl)1-piperazinyl)ethyl)5,6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazol dihydrochloride 3.5 hydrate | 5.61e-07 | 9 | 44 | 3 | ctd:C109602 | |
| Drug | 5-(N-(4-((4-ethylbenzyl)thio)phenyl)sulfamoyl)-2-methylbenzoic acid | 5.61e-07 | 9 | 44 | 3 | ctd:C000588958 | |
| Drug | Tryptamines | 5.61e-07 | 9 | 44 | 3 | ctd:D014363 | |
| Drug | sitaxsentan | 8.00e-07 | 10 | 44 | 3 | ctd:C106276 | |
| Drug | norketobemidone | 8.00e-07 | 10 | 44 | 3 | CID000161154 | |
| Drug | Haloperidol metabolite I | 1.10e-06 | 11 | 44 | 3 | CID000038282 | |
| Drug | trans-1,2-dihydro-1,2-naphthalenediol | 1.10e-06 | 11 | 44 | 3 | ctd:C507866 | |
| Drug | furafylline | 1.17e-06 | 41 | 44 | 4 | CID000003433 | |
| Drug | 4-(N-propionylanilino)piperidine | 1.46e-06 | 12 | 44 | 3 | CID000259381 | |
| Drug | carveol | 1.46e-06 | 12 | 44 | 3 | CID000007438 | |
| Drug | desethylamodiaquine | 1.46e-06 | 12 | 44 | 3 | ctd:C047386 | |
| Drug | norclozapine | 1.46e-06 | 12 | 44 | 3 | ctd:C058272 | |
| Drug | sulfaphenazole | 1.56e-06 | 44 | 44 | 4 | CID000005335 | |
| Drug | polybrominated biphenyl | 1.56e-06 | 44 | 44 | 4 | CID000042948 | |
| Drug | AC1L18GM | 1.90e-06 | 13 | 44 | 3 | CID000000092 | |
| Drug | 7-hydroxyquinoline | 1.90e-06 | 13 | 44 | 3 | CID000011378 | |
| Drug | 1'-hydroxymidazolam | 1.90e-06 | 13 | 44 | 3 | CID000107917 | |
| Drug | clozapine N-oxide | 1.90e-06 | 13 | 44 | 3 | CID000036727 | |
| Drug | 19-HETE | 2.41e-06 | 49 | 44 | 4 | CID006439528 | |
| Drug | 5-MeO-DIPT | 2.41e-06 | 14 | 44 | 3 | CID000151182 | |
| Drug | propionanilide | 2.41e-06 | 14 | 44 | 3 | CID000012107 | |
| Drug | 6-hydroxymelatonin | 2.62e-06 | 50 | 44 | 4 | CID000001864 | |
| Drug | 4-hydroxymephenytoin | 3.01e-06 | 15 | 44 | 3 | CID000119507 | |
| Drug | 8-MOP | 3.17e-06 | 118 | 44 | 5 | CID000004114 | |
| Drug | triazolam | 3.57e-06 | 54 | 44 | 4 | CID000005556 | |
| Drug | dibenzylfluorescein | 3.65e-06 | 2 | 44 | 2 | ctd:C558664 | |
| Drug | 4,4'-(hexafluoroisopropylidene)diphenol | 3.71e-06 | 16 | 44 | 3 | ctd:C571725 | |
| Drug | Amodiaquine | 3.71e-06 | 16 | 44 | 3 | ctd:D000655 | |
| Drug | 6-hydroxychlorzoxazone | 3.71e-06 | 16 | 44 | 3 | CID000002734 | |
| Drug | 1-phenylazo-2-naphthol | 3.71e-06 | 16 | 44 | 3 | ctd:C024336 | |
| Drug | 1,1,1-trichloro-2-(4-hydroxyphenyl)-2-(4-methoxyphenyl)ethane | 3.71e-06 | 16 | 44 | 3 | ctd:C495657 | |
| Drug | diosmetin | 4.49e-06 | 17 | 44 | 3 | ctd:C039602 | |
| Drug | 7-benzyloxyquinoline | 5.38e-06 | 18 | 44 | 3 | CID003035604 | |
| Drug | pleuromutilin | 5.38e-06 | 18 | 44 | 3 | CID000031326 | |
| Drug | 2,4-oxazolidinedione | 5.38e-06 | 18 | 44 | 3 | CID000097389 | |
| Drug | Lansoprazole | 5.84e-06 | 61 | 44 | 4 | ctd:D064747 | |
| Drug | BP-4,5-oxide | 5.84e-06 | 61 | 44 | 4 | CID000037786 | |
| Drug | D 617 | 6.39e-06 | 19 | 44 | 3 | CID000093168 | |
| Drug | 6|A-Hydroxycortisol | 6.39e-06 | 19 | 44 | 3 | CID000150985 | |
| Drug | aminoglutethimide | 6.59e-06 | 137 | 44 | 5 | CID000002145 | |
| Drug | chlorzoxazone | 6.65e-06 | 63 | 44 | 4 | CID000002733 | |
| Drug | N'-nitrosoanatabine | 7.50e-06 | 20 | 44 | 3 | CID000051291 | |
| Drug | tamoxifen N-oxide | 7.50e-06 | 20 | 44 | 3 | CID003033895 | |
| Drug | 3-methoxymorphinan | 7.50e-06 | 20 | 44 | 3 | CID000001671 | |
| Drug | propoxyphene | 8.51e-06 | 67 | 44 | 4 | CID000010100 | |
| Drug | piperonyl butoxide | 8.51e-06 | 67 | 44 | 4 | CID000005794 | |
| Drug | AC1L21VM | 8.74e-06 | 21 | 44 | 3 | CID000039524 | |
| Drug | nirvanol | 8.74e-06 | 21 | 44 | 3 | CID000091480 | |
| Drug | zafirlukast | 8.74e-06 | 21 | 44 | 3 | ctd:C062735 | |
| Drug | 5,6-epoxyeicosatrienoic acid | 9.03e-06 | 68 | 44 | 4 | CID000001778 | |
| Drug | (Z) Fluvoxamine | 9.57e-06 | 69 | 44 | 4 | CID000003404 | |
| Drug | 8(9)-EET | 9.57e-06 | 69 | 44 | 4 | CID000001901 | |
| Drug | N'-nitrosoanabasine | 1.01e-05 | 22 | 44 | 3 | CID000014335 | |
| Drug | azoline | 1.01e-05 | 22 | 44 | 3 | CID003013050 | |
| Drug | 1h1q | 1.01e-05 | 70 | 44 | 4 | CID000001540 | |
| Drug | DMEs | 1.07e-05 | 71 | 44 | 4 | CID003038361 | |
| Drug | 5-(4-(3-(4-cyclohexyl-2-propylphenoxy)propoxy)phenyl)-1,3-oxazolidine-2,4-dione | 1.09e-05 | 3 | 44 | 2 | ctd:C502236 | |
| Drug | picoxystrobin | 1.09e-05 | 3 | 44 | 2 | ctd:C556557 | |
| Drug | 2-hydroxychlorpropamide | 1.09e-05 | 3 | 44 | 2 | CID003082454 | |
| Drug | Cyclohexenes | 1.09e-05 | 3 | 44 | 2 | ctd:D053138 | |
| Drug | mono-N-demethyladinazolam | 1.09e-05 | 3 | 44 | 2 | ctd:C050132 | |
| Drug | ortho-Aminobenzoates | 1.09e-05 | 3 | 44 | 2 | ctd:D062367 | |
| Drug | Delavirdine | 1.09e-05 | 3 | 44 | 2 | ctd:D020008 | |
| Drug | carteolol | 1.13e-05 | 72 | 44 | 4 | CID000002583 | |
| Drug | methoxychlor | 1.13e-05 | 72 | 44 | 4 | CID000004115 | |
| Drug | 3-hydroxymethylantipyrine | 1.16e-05 | 23 | 44 | 3 | CID000123963 | |
| Drug | 3'-amino-3'-deoxythymidine | 1.16e-05 | 23 | 44 | 3 | CID000108074 | |
| Drug | N-nitrosomethylethylamine | 1.32e-05 | 24 | 44 | 3 | CID000025418 | |
| Drug | cinnamic acid | 1.32e-05 | 24 | 44 | 3 | ctd:C029010 | |
| Drug | Ticlopidine | 1.50e-05 | 25 | 44 | 3 | ctd:D013988 | |
| Drug | methylpropylnitrosamine | 1.50e-05 | 25 | 44 | 3 | CID000013545 | |
| Drug | N-nitrosopiperidine | 1.50e-05 | 25 | 44 | 3 | CID000007526 | |
| Drug | Aconitine | 1.50e-05 | 25 | 44 | 3 | ctd:D000157 | |
| Drug | Tranylcypromine | 1.50e-05 | 25 | 44 | 3 | ctd:D014191 | |
| Disease | X-21258 measurement | 2.68e-09 | 3 | 42 | 3 | EFO_0800802 | |
| Disease | mucinous adenocarcinoma (is_marker_for) | 2.68e-08 | 5 | 42 | 3 | DOID:3030 (is_marker_for) | |
| Disease | X-14473 measurement | 1.98e-06 | 2 | 42 | 2 | EFO_0021370 | |
| Disease | cystitis (is_marker_for) | 1.98e-06 | 2 | 42 | 2 | DOID:1679 (is_marker_for) | |
| Disease | cyclo(leu-pro) measurement | 5.93e-06 | 3 | 42 | 2 | EFO_0800676 | |
| Disease | sputum mucin-5B amount | 5.93e-06 | 3 | 42 | 2 | OBA_2050332 | |
| Disease | S-6-hydroxywarfarin to S-warfarin ratio measurement | 7.58e-06 | 88 | 42 | 4 | EFO_0803332 | |
| Disease | S-warfarin to R-warfarin ratio measurement | 1.03e-05 | 95 | 42 | 4 | EFO_0803331 | |
| Disease | mucositis (biomarker_via_orthology) | 1.97e-05 | 5 | 42 | 2 | DOID:0080178 (biomarker_via_orthology) | |
| Disease | biliary tract benign neoplasm (is_marker_for) | 4.13e-05 | 7 | 42 | 2 | DOID:0050625 (is_marker_for) | |
| Disease | glycine conjugate of C10H14O2 (1) measurement | 4.13e-05 | 7 | 42 | 2 | EFO_0800655 | |
| Disease | common bile duct neoplasm (is_marker_for) | 5.51e-05 | 8 | 42 | 2 | DOID:4608 (is_marker_for) | |
| Disease | ecosanoids measurement | 6.68e-05 | 55 | 42 | 3 | EFO_0020044 | |
| Disease | bringing up phlegm, sputum or mucus on most days, self-reported | 7.08e-05 | 9 | 42 | 2 | EFO_0009824 | |
| Disease | plasma clozapine-to-N-desmethylclozapine ratio measurement | 7.08e-05 | 9 | 42 | 2 | EFO_0600040 | |
| Disease | pneumonia (implicated_via_orthology) | 8.84e-05 | 10 | 42 | 2 | DOID:552 (implicated_via_orthology) | |
| Disease | allergic conjunctivitis (is_marker_for) | 8.84e-05 | 10 | 42 | 2 | DOID:11204 (is_marker_for) | |
| Disease | allergic rhinitis (biomarker_via_orthology) | 8.84e-05 | 10 | 42 | 2 | DOID:4481 (biomarker_via_orthology) | |
| Disease | cholangiocarcinoma (is_marker_for) | 1.05e-04 | 64 | 42 | 3 | DOID:4947 (is_marker_for) | |
| Disease | X-11308 measurement | 1.08e-04 | 11 | 42 | 2 | EFO_0800693 | |
| Disease | ulcerative colitis | 1.10e-04 | 335 | 42 | 5 | EFO_0000729 | |
| Disease | thymol sulfate measurement | 1.29e-04 | 12 | 42 | 2 | EFO_0021170 | |
| Disease | 16a-hydroxy DHEA 3-sulfate measurement | 2.05e-04 | 15 | 42 | 2 | EFO_0800301 | |
| Disease | X-17654 measurement | 2.05e-04 | 15 | 42 | 2 | EFO_0800784 | |
| Disease | andro steroid monosulfate C19H28O6S (1) measurement | 2.34e-04 | 16 | 42 | 2 | EFO_0800305 | |
| Disease | otitis media (biomarker_via_orthology) | 2.65e-04 | 17 | 42 | 2 | DOID:10754 (biomarker_via_orthology) | |
| Disease | metabolonic lactone sulfate measurement | 3.33e-04 | 19 | 42 | 2 | EFO_0800659 | |
| Disease | response to mitochondrial complex I inhibitor | 3.33e-04 | 19 | 42 | 2 | EFO_0600033 | |
| Disease | Inhalant adrenergic use measurement | 3.49e-04 | 96 | 42 | 3 | EFO_0009941 | |
| Disease | progranulin measurement | 4.49e-04 | 22 | 42 | 2 | EFO_0004625 | |
| Disease | Oral ulcer | 4.80e-04 | 107 | 42 | 3 | HP_0000155 | |
| Disease | platelet reactivity measurement, response to clopidogrel | 4.91e-04 | 23 | 42 | 2 | EFO_0004985, GO_1903493 | |
| Disease | hematocrit | 5.13e-04 | 1011 | 42 | 7 | EFO_0004348 | |
| Disease | asthma | 6.40e-04 | 751 | 42 | 6 | MONDO_0004979 | |
| Disease | arteriosclerosis (is_marker_for) | 7.84e-04 | 29 | 42 | 2 | DOID:2349 (is_marker_for) | |
| Disease | Brain Tumor, Primary | 1.02e-03 | 33 | 42 | 2 | C0750974 | |
| Disease | Primary malignant neoplasm of brain | 1.02e-03 | 33 | 42 | 2 | C0750979 | |
| Disease | Recurrent Brain Neoplasm | 1.02e-03 | 33 | 42 | 2 | C0750977 | |
| Disease | Neoplasms, Intracranial | 1.02e-03 | 33 | 42 | 2 | C1527390 | |
| Disease | clopidogrel metabolite measurement | 1.02e-03 | 33 | 42 | 2 | EFO_0007966 | |
| Disease | Benign neoplasm of brain, unspecified | 1.02e-03 | 33 | 42 | 2 | C0496899 | |
| Disease | eosinophil count | 1.04e-03 | 1488 | 42 | 8 | EFO_0004842 | |
| Disease | low density lipoprotein cholesterol measurement, C-reactive protein measurement | 1.14e-03 | 35 | 42 | 2 | EFO_0004458, EFO_0004611 | |
| Disease | blood molybdenum measurement | 1.35e-03 | 38 | 42 | 2 | EFO_0007582 | |
| Disease | Malignant neoplasm of brain | 1.35e-03 | 38 | 42 | 2 | C0153633 | |
| Disease | Brain Neoplasms | 1.42e-03 | 39 | 42 | 2 | C0006118 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PCPQPGSCDFESGLC | 966 | Q6UXC1 | |
| CVPPLEPKLAAGCCG | 6 | Q6DCA0 | |
| CFACTICKRPFPPGD | 181 | O14639 | |
| CDLPEFCTGKSPHCP | 481 | Q9H013 | |
| ASPCDPTFILGCAPC | 161 | P10632 | |
| CDPEDGQCPCKPGVI | 1936 | Q9HCU4 | |
| PFGECCPICPTDLAT | 81 | P02458 | |
| LAAGCKPIIPPGACC | 811 | O95980 | |
| CPDCGADKPSPCGRS | 381 | O75808 | |
| PCFPSVHCVPGKGCE | 5081 | Q99102 | |
| PGLCLCDCPGLVMPS | 431 | Q9H089 | |
| VCKDLPCPGTCALEG | 381 | Q02817 | |
| EPKRIFFGPVSCPCC | 446 | Q5VWM3 | |
| PCPAPGISALDECGC | 51 | Q8WX77 | |
| CETCRCELPGGPPSD | 5401 | P98088 | |
| CPVFAEVGCSPCGAP | 586 | Q9Y4D8 | |
| IPFTCPCKDGGPDTA | 3921 | Q9Y4D8 | |
| PGCPSPCGKYISCAE | 616 | P05107 | |
| ECPAGGPFVCKCREP | 181 | Q13467 | |
| ASPCDPTFILGCAPC | 161 | P33261 | |
| CPGSCPSLSAPEGCE | 3551 | Q9Y6R7 | |
| GCGECVSKPCPSPCT | 4641 | Q9Y6R7 | |
| VKVPGECCPVCEEPT | 446 | Q9NZV1 | |
| GVCVKPDRCLCPPDF | 161 | Q8N2S1 | |
| PDRCLCPPDFAGKFC | 166 | Q8N2S1 | |
| ASPCDPTFILGCAPC | 161 | P33260 | |
| ASPCDPTFILGCAPC | 161 | P11712 | |
| FCQECGSPVPPIFGC | 226 | Q9NVP4 | |
| QESKCFPCPAEGCPK | 311 | P54317 | |
| CCDCCSPVPGQKGEP | 101 | A6NHN0 | |
| EGQPSPDGCLCPCSL | 901 | Q7Z6I6 | |
| GMDPNPLGCPDCACK | 611 | Q5TGY1 | |
| PLGCPDCACKTQGPS | 616 | Q5TGY1 | |
| TFCDPSNGDCPCKPG | 411 | Q9HB63 | |
| CGPDKAPALSPGSCC | 1191 | Q6ZWJ8 | |
| FFGPVSCPCCGMSPT | 451 | Q5SWL8 | |
| TFPGCICVKTPCLPG | 71 | Q53H47 | |
| LCLCPPGFIGPDCEV | 261 | Q99466 | |
| KANCLCPDGSPGCAP | 646 | Q99466 | |
| VPCECPEGLCHPVSG | 396 | Q14162 | |
| CIPLDKGFSCECVPG | 1051 | O75094 | |
| GEKFAPGPSACPCLC | 166 | Q2TAL6 | |
| EEGPFPCPECGKVFL | 316 | Q8NBB4 | |
| CGCFCEPLPGEPTKT | 156 | Q9NSY2 | |
| CSICGLEPPCPEGSQ | 1886 | Q9NY15 | |
| PPTMPLEFVCCIGGC | 726 | Q13472 | |
| SVKCEGHCPCPSDKP | 176 | Q9BQ16 | |
| EPCAATAPECPYCKG | 661 | Q9H9P5 | |
| GERPFPCPTCGKCFT | 416 | Q5T619 | |
| EYPVGSECCPKCSPG | 46 | Q92956 | |
| ACGELTGTVCEPCPP | 66 | Q92956 | |
| PDCPEVCTCVPGGLA | 41 | Q2I0M4 |